PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
73.63
+0.32 (0.44%)
Aug 10, 2026, 1:21 PM EDT - Market open
PTC Therapeutics Employees
PTC Therapeutics had 991 employees as of December 31, 2025. The number of employees increased by 52 or 5.54% compared to the previous year.
Employees
991
Change (1Y)
52
Growth (1Y)
5.54%
Revenue / Employee
$1,017,915
Profits / Employee
-$38,731
Market Cap
6.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 991 | 52 | 5.54% | 991 | 0 |
| Dec 31, 2024 | 939 | -116 | -11.00% | 939 | 0 |
| Dec 31, 2023 | 1,055 | -355 | -25.18% | 988 | 67 |
| Dec 31, 2022 | 1,410 | 233 | 19.80% | 1,402 | 8 |
| Dec 31, 2021 | 1,177 | 210 | 21.72% | 1,167 | 10 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 418 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
| Dianthus Therapeutics | 92 |
PTCT News
- 10 days ago - PTC Therapeutics price target raised to $96 from $95 at BofA - TheFly
- 10 days ago - PTC Therapeutics price target raised to $104 from $93 at Morgan Stanley - TheFly
- 10 days ago - PTC Therapeutics price target raised to $106 from $93 at Wells Fargo - TheFly
- 10 days ago - PTC Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 10 days ago - PTC Therapeutics Earnings release: Q2 2026 - Filings
- 10 days ago - PTC Therapeutics Quarterly report: Q2 2026 - Filings
- 10 days ago - PTC Therapeutics reports Q2 EPS 92c, consensus 34c - TheFly
- 10 days ago - PTC Therapeutics raises 2026 revenue view to $1.18B-$1.28B from $1.08B-$1.18B - TheFly